Last week, earnings remained in focus with several companies reporting their third quarter results. While AbbVie’s (ABBV – Analyst Report) results remained strong with the company raising its outlook, companies like Regeneron (REGN – Analyst Report) and Aegerion (AEGR – Analyst Report) narrowed their sales outlooks for their key products.Among all this, Geron (GERN – Analyst Report) made it to […]
Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]
It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]
It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]
That bright neon sign you’re looking at are biotech stocks flashing, “Buy me!”So put down your morning joe. Go ahead, do it. And ignore all incoming e-mail for the next few minutes. Because the biotech breakout has arrived — and it can make you a bundle over the next few months.That’s right. Forget about this month’s stock roller-coaster ride. Yeah, sure, it […]
By Ben LevisohnYes, say the folks at Nomura, who recommend buying Celgene (CELG), Receptos(RCPT), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), and Alexion Pharmaceuticals (ALXN), in that order. Analyst M. Ian Somaiya and team explain why:
October has historically been a weak month for biotech, with the Nasdaq Biotechnology Index underperforming the S&P 500 in 14 out the last 20 years. We believe […]
The Ebola virus has landed in the United States, after Thomas Eric Duncan flew from Liberia to Texas. He was released by a hospital in Dallas, despite telling hospital staff that he came from Liberia. He came in contact with up to 20 people, including 5 schoolchildren since touching down in Dallas. The CDC is monitoring these people, but I have […]
While biotech stocks saw an early selloff Friday, the shares of three companies in the sector have plenty of potential left, John Schroer of Allianz Global Investors said on CNBC.Biogen Idec is his top pick.”Leading company in the [multiple sclerosis] space. They have some very strong earnings growth, 20 to 25 percent earnings growth over the next three years. And […]
Benchmarks ended mostly in the negative territory on Wednesday after a drop in Apple shares weighed on the broader markets. A possibility of a cease-fire between Ukraine and Russia had initially lifted the markets. Meanwhile, investors were reluctant to bet big bucks ahead of the European Central Bank’s monthly policy meeting on Thursday.For a look at the issues currently facing […]
TOKYO (AP) — Asian stock markets were lackluster Thursday after Wall Street fell and as investors looked ahead to a European Central Bank meeting and U.S. economic data.KEEPING SCORE: Japan’s Nikkei 225 was down 0.2 percent at 15,703.89 while South Korea’s Kospi added 0.2 percent to 2,055.58. Hong Kong’s Hang Seng shed 0.4 percent to 25,229.91. Markets in Southeast Asia […]
